IRIS
CARLO STELLA, CARMELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.627
AS - Asia 6.462
EU - Europa 1.733
SA - Sud America 1.166
AF - Africa 309
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 19.318
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.403
SG - Singapore 4.304
BR - Brasile 948
CN - Cina 848
VN - Vietnam 626
FI - Finlandia 368
DE - Germania 256
IE - Irlanda 252
NG - Nigeria 205
HK - Hong Kong 181
FR - Francia 161
IT - Italia 161
GB - Regno Unito 137
CA - Canada 128
IN - India 98
NL - Olanda 77
AR - Argentina 67
MX - Messico 61
TR - Turchia 55
RU - Federazione Russa 50
BD - Bangladesh 49
IQ - Iraq 48
SE - Svezia 43
EC - Ecuador 35
CZ - Repubblica Ceca 31
ES - Italia 30
PK - Pakistan 29
IL - Israele 28
CL - Cile 27
UA - Ucraina 27
PL - Polonia 25
ID - Indonesia 24
BE - Belgio 23
ZA - Sudafrica 22
CO - Colombia 21
PY - Paraguay 21
JP - Giappone 20
UZ - Uzbekistan 19
VE - Venezuela 19
MA - Marocco 18
SA - Arabia Saudita 18
LT - Lituania 16
EG - Egitto 15
PH - Filippine 15
AT - Austria 14
JO - Giordania 13
KE - Kenya 13
PE - Perù 13
RO - Romania 12
TN - Tunisia 12
UY - Uruguay 12
AU - Australia 10
DO - Repubblica Dominicana 9
AZ - Azerbaigian 8
IR - Iran 8
MY - Malesia 8
NP - Nepal 8
A2 - ???statistics.table.value.countryCode.A2??? 7
DZ - Algeria 7
CR - Costa Rica 6
DK - Danimarca 6
JM - Giamaica 6
KR - Corea 6
AM - Armenia 5
BG - Bulgaria 5
CH - Svizzera 5
ET - Etiopia 5
GR - Grecia 5
LK - Sri Lanka 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
HN - Honduras 4
HR - Croazia 4
KZ - Kazakistan 4
LV - Lettonia 4
OM - Oman 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
GE - Georgia 3
HU - Ungheria 3
LB - Libano 3
PS - Palestinian Territory 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
GA - Gabon 2
GT - Guatemala 2
KH - Cambogia 2
MD - Moldavia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
Totale 19.300
Salva come PNG Salva come JPEG
Città #
Singapore 1.968
Wilmington 1.310
Chandler 1.266
The Dalles 685
Ashburn 609
Dallas 591
San Mateo 502
Shanghai 476
San Jose 398
Helsinki 362
Ann Arbor 332
Dublin 251
Leawood 243
Boardman 235
Lawrence 225
Princeton 225
Benin City 205
Ho Chi Minh City 189
Hong Kong 173
Hanoi 154
New York 142
Beijing 135
Fairfield 124
Paris 121
Woodbridge 95
São Paulo 77
Amsterdam 74
Los Angeles 69
Toronto 68
London 66
Columbus 63
Seattle 50
Milan 44
Santa Clara 41
Da Nang 38
Rio de Janeiro 31
San Diego 31
Munich 28
Montreal 27
Norwalk 27
Falls Church 26
Phoenix 24
Brno 23
Brussels 23
Brasília 22
Council Bluffs 22
Falkenstein 22
Warsaw 22
Belo Horizonte 20
Naples 20
Brooklyn 19
Haiphong 19
Orem 19
Tashkent 19
Frankfurt am Main 18
Campinas 17
Can Tho 15
Curitiba 15
Guayaquil 15
Kocaeli 15
Biên Hòa 14
Chennai 14
Dhaka 14
Stockholm 14
Amman 13
Baghdad 13
Monmouth Junction 13
Moscow 13
Pune 13
Tokyo 13
Boston 12
Chicago 12
Gunzenhausen 12
Houston 12
Istanbul 11
Johannesburg 11
Mexico City 11
Nuremberg 11
Vienna 11
Ankara 10
Asunción 10
Atlanta 10
Hillsboro 10
Montevideo 10
Porto Alegre 10
Redmond 10
Abbiategrasso 9
Guarulhos 9
Lima 9
Manchester 9
San Francisco 9
Thái Nguyên 9
Baku 8
Buffalo 8
Hải Dương 8
Nairobi 8
Quito 8
Recife 8
Santiago 8
Thái Bình 8
Totale 12.570
Salva come PNG Salva come JPEG
Nome #
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis 171
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogenic stem call transplantation from a HLA identical sibling 134
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®) 133
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH) 132
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 123
ACQUIRED CYCLIC THROMBOCYTOPENIATHROMBOCYTOSIS WITH PERIODIC DEFECT OF PLATELET-FUNCTION 120
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma 117
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K delta/gamma Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study 115
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments 113
Primary refractory and early-relapsed Hodgkin's lymphoma : strategies for therapeutic targeting based on the tumour microenvironment 111
A case of acute myeloid leukemia, with pseudo-Pelger neutrophils 107
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome 106
D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies 104
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation 104
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma 102
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant 97
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNA 96
Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis 96
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 93
Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation 93
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 93
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma 93
Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy 91
Radioimmunotherapy and secondary leukemia : a case report 89
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection 89
Amifostine (WR-2721) selective protection against melphalan genotoxicity 89
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 89
[Mesenchymal stem cells: biology and clinical applications] 89
Detection of maternal progenitor cells in human umbilical cord blood by single-colony karyotyping 88
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade? 88
Cell therapy: achievements and perspectives 87
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes 87
"Overshoot" phenomenon in circulating granulocytic progenitor cell growth during remission of blast crisis in a case of CML 86
Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice 86
AUTOLOGOUS TRANSPLANT FOR CHRONIC MYELOGENOUS LEUKEMIA USING MARROW TREATED EX-VIVO WITH MAFOSFAMIDE 86
Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-a: evidence for a tyrosine-kinase-dependent process 85
Bleomycin genotoxicity and amifostine (WR-2721) cell protection in normal leukocytes vs. K562 tumoral cells 85
EFFECT OF RECOMBINANT GAMMA-INTERFERON ON THE PROLIFERATIVE ACTIVITY OF CULTURED LEUKEMIC-CELLS 84
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts 84
Tumor-derived PGD2 and NKp30 –B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 83
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia 82
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma : a single institution experience 82
UMBILICAL-CORD BLOOD AS A SOURCE OF HEMATOPOIETIC STEM-CELLS - FROM RESEARCH TO CLINIC 81
Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphoma 81
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection 81
Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses 80
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia : evidence for premature aging of the myeloid compartment 80
INVITRO MEGAKARYOCYTOPOIESIS IN PATIENTS WITH HIV-RELATED THROMBOCYTOPENIC PURPURA 80
Specific histone patterns and acetylase/deacetylase activity at the breakpoint-cluster region of the human MLL gene 80
EFFECT OF RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA ON HUMAN-BONE MARROW DERIVED MEGAKARYOCYTIC PROGENITOR CELLS 79
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia 79
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells 79
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide 79
Stem cells and stem cell transplantation 78
BIOLOGICAL ASPECTS AND CLINICAL-APPLICATIONS OF LONG-TERM BONE-MARROW CULTURE - A MEETING REPORT 77
Detection of minimal residual disease in hematopoietic progenitor cell harvests : lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma 77
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients 77
The parallel between CD45 expression and extra-medullary evolution in aggressive myeloma with high serum lactate dehydrogenase 76
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells 76
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies : posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery 76
ESTABLISHMENT OF 2 EPSTEIN-BARR VIRUS NEGATIVE BURKITT CELL-LINES FROM A PATIENT WITH AIDS AND B-CELL LYMPHOMA 75
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma 75
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunological responses in indolent B-cell lymphoma patients with relapsed and measurable disease : a pilot study 75
Autophagy as a pathogenic mechanism and drug target in lymphoproliferative disorders 75
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA 74
Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients 74
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 74
Stem cell manipulation: why and how performing peripheral blood progenitor cell purging 74
BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts 74
Ex vivo manipulation of hematopoietic stem cells for transplantation: The potential role of amifostine 73
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias 73
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases 73
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice 73
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma 73
Phase II study of sorafenib in patients with relapsed or refractory lymphoma 73
[Biological screening of immuno-mediated marrow insufficiency by means of the CFU-GM assay] 72
CD34-POSITIVE CELLS - BIOLOGY AND CLINICAL RELEVANCE 72
In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor 72
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen) 72
The novel PI3K-ò inhibitor TGR-1202 enhances brentuximab vedotin-induced Hodgkin lymphoma cell death via mitotic arrest. 72
INVITRO AND INVIVO EFFECTS OF RECOMBINANT INTERFERON GAMMA ON THE GROWTH OF HEMATOPOIETIC PROGENITOR CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME 72
B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY 72
Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma 72
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (mTRAIL) 72
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors. 72
Transforming growth factor beta(3) inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis 72
Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside 71
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells 71
Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors 71
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors : mature results of an Italian randomized phase II study 71
REGULATION OF EARLY HEMATOPOIESIS IN SERUM-DEPRIVED CULTURES OF MAFOSFAMIDE-TREATED AND UNTREATED CD34-ENRICHED BONE-MARROW CELLS 70
Targeting cancer cells and tumor microenvironment in preclinical and clinical models of Hodgkin lymphoma using the dual PI3Kd/G inhibitor RP6530 70
The anti-HLA-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing NOD/SCID mice 70
Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma 70
NATURAL-KILLER-CELL REGENERATION AFTER TRANSPLANTATION WITH MAFOSFAMIDE PURGED AUTOLOGOUS BONE-MARROW 70
Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed 70
Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment 69
RECOMBINANT GAMMA-INTERFERON INDUCES INVITRO MONOCYTIC DIFFERENTIATION OF BLAST CELLS FROM PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA AND MYELODYSPLASTIC SYNDROMES 69
Current role of autologous and allogeneic stem cell transplantation for relapsed and refractory Hodgkin Lymphoma 69
Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide 69
Totale 8.478
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.722
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021543 0 0 0 0 0 0 0 0 0 303 8 232
2021/20221.277 68 5 19 275 19 20 30 165 130 193 286 67
2022/20233.390 487 102 293 411 326 292 0 310 604 281 236 48
2023/20241.820 139 218 335 41 30 128 67 132 24 36 280 390
2024/20253.375 88 65 33 69 85 328 197 404 531 802 403 370
2025/20267.435 1.247 462 642 743 233 331 2.499 464 467 347 0 0
Totale 19.562